| Healthcare Policy and Management | Lifetime | 31 | US 24 | 99.59 |
| Primary Care and Health Outcomes | Lifetime | 39 | US 25 | 99.53 |
| Global Health Care Issues | Lifetime | 40 | US 16 | 99.36 |
| Chronic Disease Management Strategies | Lifetime | 86 | US 38 | 99.07 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 249 | US 119 | 99.23 |
| Pharmaceutical Economics and Policy | Lifetime | 56 | US 33 | 98.77 |
| Healthcare Systems and Reforms | Lifetime | 93 | US 27 | 98.44 |
| Patient Satisfaction in Healthcare | Lifetime | 140 | US 94 | 98.22 |
| Healthcare cost, quality, practices | Lifetime | 132 | US 78 | 97.92 |
| Pharmaceutical industry and healthcare | Lifetime | 88 | US 60 | 96.46 |
| Biosimilars and Bioanalytical Methods | Lifetime | 376 | US 137 | 94.32 |
| Pharmaceutical studies and practices | Lifetime | 977 | US 434 | 94.38 |
| Global Health Workforce Issues | Lifetime | 841 | US 318 | 92.28 |
| Diversity and Career in Medicine | Lifetime | 841 | US 623 | 91.28 |
| Medication Adherence and Compliance | Lifetime | 893 | US 446 | 90.42 |
| Medical Education and Admissions | Lifetime | 940 | US 555 | 83.43 |
| Biotechnology and Related Fields | Lifetime | 753 | US 307 | 76.05 |
| Healthcare Policy and Management | 2021-2025 | 49 | US 41 | 97.24 |
| Pharmaceutical Economics and Policy | 2021-2025 | 42 | US 17 | 96.49 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 384 | US 131 | 96.38 |
| Primary Care and Health Outcomes | 2021-2025 | 92 | US 49 | 96.04 |
| Patient Satisfaction in Healthcare | 2021-2025 | 80 | US 36 | 93.94 |
| Pharmaceutical studies and practices | 2021-2025 | 123 | US 47 | 92.17 |
| Healthcare cost, quality, practices | 2021-2025 | 152 | US 71 | 90.85 |
| Global Health Care Issues | 2021-2025 | 349 | US 76 | 87.78 |
| Pharmaceutical industry and healthcare | 2021-2025 | 38 | US 17 | 87.86 |
| Biotechnology and Related Fields | 2021-2025 | 57 | US 18 | 77.88 |
| Medication Adherence and Compliance | 2021-2025 | 719 | US 243 | 73.18 |